Uncategorized
FDA delays decision on Orca Bio cell therapy after filing more manufacturing data
The FDA has postponed its deadline on whether to approve Orca Bio’s T cell therapy by three months to July 6.
The agency was expected to reach a verdict by April 6, but pushed back …